11-44114268-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_207122.2(EXT2):​c.710C>T​(p.Ser237Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00376 in 1,614,022 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0022 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0039 ( 22 hom. )

Consequence

EXT2
NM_207122.2 missense

Scores

3
8
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:9O:1

Conservation

PhyloP100: 7.76

Publications

8 publications found
Variant links:
Genes affected
EXT2 (HGNC:3513): (exostosin glycosyltransferase 2) This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of multiple exostoses. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
EXT2 Gene-Disease associations (from GenCC):
  • exostoses, multiple, type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P
  • seizures-scoliosis-macrocephaly syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • hereditary multiple osteochondromas
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013198048).
BP6
Variant 11-44114268-C-T is Benign according to our data. Variant chr11-44114268-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 134212.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00223 (340/152290) while in subpopulation NFE AF = 0.00332 (226/68020). AF 95% confidence interval is 0.00297. There are 2 homozygotes in GnomAd4. There are 166 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EXT2NM_207122.2 linkc.710C>T p.Ser237Leu missense_variant Exon 4 of 14 ENST00000533608.7 NP_997005.1 Q93063-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EXT2ENST00000533608.7 linkc.710C>T p.Ser237Leu missense_variant Exon 4 of 14 1 NM_207122.2 ENSP00000431173.2 Q93063-1

Frequencies

GnomAD3 genomes
AF:
0.00223
AC:
340
AN:
152172
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000459
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00527
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00332
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00269
AC:
677
AN:
251452
AF XY:
0.00249
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.00124
Gnomad ASJ exome
AF:
0.000397
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00577
Gnomad NFE exome
AF:
0.00422
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00392
AC:
5728
AN:
1461732
Hom.:
22
Cov.:
31
AF XY:
0.00371
AC XY:
2701
AN XY:
727176
show subpopulations
African (AFR)
AF:
0.000598
AC:
20
AN:
33472
American (AMR)
AF:
0.00134
AC:
60
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.000383
AC:
10
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86252
European-Finnish (FIN)
AF:
0.00535
AC:
286
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.00465
AC:
5167
AN:
1111896
Other (OTH)
AF:
0.00296
AC:
179
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
310
620
929
1239
1549
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00223
AC:
340
AN:
152290
Hom.:
2
Cov.:
32
AF XY:
0.00223
AC XY:
166
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.000457
AC:
19
AN:
41558
American (AMR)
AF:
0.00229
AC:
35
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00527
AC:
56
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00332
AC:
226
AN:
68020
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00324
Hom.:
3
Bravo
AF:
0.00212
TwinsUK
AF:
0.00620
AC:
23
ALSPAC
AF:
0.00571
AC:
22
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00291
AC:
25
ExAC
AF:
0.00276
AC:
335
EpiCase
AF:
0.00322
EpiControl
AF:
0.00338

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:9Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:4
Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

EXT2: BS1, BS2 -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Exostoses, multiple, type 2 Benign:3
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2Other:1
Jul 10, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Nov 24, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.45
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.58
D;.;.;D
Eigen
Benign
0.067
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.90
.;D;D;D
M_CAP
Uncertain
0.095
D
MetaRNN
Benign
0.013
T;T;T;T
MetaSVM
Uncertain
0.73
D
MutationAssessor
Benign
1.0
L;L;.;L
PhyloP100
7.8
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-0.13
N;N;N;N
REVEL
Pathogenic
0.65
Sift
Benign
0.65
T;T;T;T
Sift4G
Benign
0.84
T;T;T;T
Polyphen
0.0090
B;B;.;B
Vest4
0.87
MVP
1.0
MPC
0.20
ClinPred
0.042
T
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.086
gMVP
0.83
Mutation Taster
=26/74
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139525250; hg19: chr11-44135818; API